Regulatory & Legal

Demand The Limits Injury Attorneys' client-first model fuels explosive growth, earning a top spot on Inc.'s prestigious Southeast list despite new hurdles.

E*TRADE's latest study reveals a surprising retail investor playbook: seeking safety in staples while cashing out of a booming energy sector.

Century Health and VCU are building a massive AI-driven database to decode steatotic liver disease, a silent epidemic affecting nearly 2 billion people.

A massive data center network is planned for Asia, but a closer look at the partners reveals a complex picture of ambition, innovation, and high-stakes risk.

A new executive order deputizes the USPS in election integrity, sparking legal challenges and warnings it will disenfranchise rural voters and bust the budget.

CubicPV earns a top GreenTech nod from TIME for its record-setting perovskite solar tech, but can its durability-first focus win in a high-stakes market?

Reprotech and TMRW Life Sciences combine, creating a tech-driven titan set to manage over 1M fertility specimens and reshape the future of IVF storage.

How does an 82-year-old moving company become one of the region's fastest-growing firms? Interstate's story of legacy, strategy, and community impact.

An innovative dinner series pairs star chefs with a high-tech food recycler, aiming to transform LA’s approach to food waste, one plate at a time.

Preclinical data suggests an investigational drug can shift burn wounds from a state of chronic inflammation toward active regeneration and repair.

Independent Living Systems leads the Latino Leaders Index 500, leveraging its massive growth to reshape care for Florida's most vulnerable populations.

The blank-check firm's unit split offers investor flexibility, but what does it signal about its search for a merger in today's selective SPAC market?

SQF Edition 10 is here, moving beyond checklists to demand a measurable food safety culture. Discover what this means for the industry's future.

New federal rules make buying fake reviews a costly crime. Businesses now face $50,000+ fines per violation and digital ruin from AI-powered crackdowns.

With FDA clearance, Zeto New Wave™ promises to slash EEG wait times and ease staff shortages, making critical brain health data more accessible.

After a period of limited availability, the Ellipsys Vascular Access System is set for a 2026 relaunch, promising a less invasive option for dialysis patients.

With FDA clearance for clinical trials, CanWell Pharma’s novel CAN016 ADC brings a two-pronged attack against drug-resistant HER2-positive cancers.

AvenCell has dosed the first patient with AVC-203, a novel allogeneic CAR-T therapy, aiming to make advanced cancer treatment more accessible and effective.

Scientists propose a unifying model combining 'viral mimicry' and 'cancer dark matter,' potentially revolutionizing how our immune system recognizes and fights tumors.

Arcosa sheds its cyclical barge business for $450M to double down on high-growth construction materials, signaling a major shift to capitalize on U.S. infrastructure.